Services
Discovery Services
Attrition Reducing Technologies (ART) *NEW CATALOGUE!*
Development Services
Bioanalysis and PK
Biologics and Biomarkers
Oncology
Attrition Reducing Technologies (ART)
Accelera is able to offer integrated preclinical profiling platforms called Attrition Reducing Technologies (ART) in the area of ADME/Tox, designed to accelerate the lead optimisation phase. ART allows sponsors to identify the most promising drug candidates at an early stage, while at the same time de-prioritise those with a high risk of failure during the development phase.
To request a free PDF copy of the new ART catalogue, click here
Accelera is able to offer integrated preclinical profiling platforms called Attrition Reducing Technologies (ART) in the area of ADME/Tox, designed to accelerate the lead optimisation phase. ART allows sponsors to identify the most promising drug candidates at an early stage, while at the same time de-prioritise those with a high risk of failure during the development phase.
To request a free PDF copy of the new ART catalogue, click here